Table S1.

List of evaluated cardiovascular drugs

Anticoagulants	Antiplatelet drugs	ACE inhibitors	ARBs	Beta-blockers	Calcium channel blockers	Statins	Other lipid lowering drugs	Inotropic drugs	Diuretics	Other CV drugs
Heparin	Aspirin	Benazepril	Azilsartan	Acebutolol	Amlodipine	Atorvastatin	Fenofibrate	Digoxin	Acetazolamide	Amiodarone
LMWH	Dipyridamole	Captopril	Candesartan	Atenolol	Diltiazem	Fluvastatin	Gemfibrozil	Dobutamine	Amiloride	Flecainide
Warfarin	Clopidogrel	Enalapril	Eprosartan	Betaxolol	Felodipine	Lovastatin	Ezetimibe	Milrinone	Chlorthalidone	Ibutilide
Apixaban	Prasugrel	Fosinopril	Irbesartan	Bisoprolol	Nifedipine	Pitavastatin	Niacin		Furosemide	Lidocaine
Rivaroxaban	Ticagrelor	Lisinopril	Losartan	Carvedilol	Nimodipine	Pravastatin			HCTZ	Procainamide
Edoxaban		Moexipril	Olmesartan	Labetalol	Nisoldipine	Rosuvastatin			Indapamide	Propafenone
Dabigatran		Perindopril	Telmisartan	Metoprolol	Verapamil	Simvastatin			Spironolactone	Quinidine
		Quinapril	Valsartan	Nadolol					Torsemide	Ivabradine
		Ramipril		Propranolol						Aliskiren
		Trandolapril		Sotalol						Sacubitril/Valsartan
										Cilostazol
										Nitroglycerin
										Nitroprusside

LMWH - low molecular weight heparin (enoxaparin/dalteparin), ACE - angiotensin converting enzyme; ARBs - angiotensin II receptor blockers; HCTZ - hydrochlorothiazide; CV - cardiovascular